Corbus Pharmaceuticals Holdings, Inc. Marketable Securities (Current)
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Marketable Securities (Current) of $69.74 million as of 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2021-11-12
- 2021-09-30: Marketable Securities, Current $69.74M.
- 2021-06-30: Marketable Securities, Current $70.37M.
- 2021-03-31: Marketable Securities, Current $57.40M.
| Period end | Marketable Securities, Current |
|---|---|
| 2021-09-30 | $69.74M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $70.37M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $57.40M 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |